Login
home
about us
news center
products
investors
licensing
research
careers
Overview
Media Resources
Press Release Archive
All Press Releases
Business Development News
Corporate News
Financial News
Product News
R&D News
All Press Releases
02.23.2006
Replidyne and Forest Laboratories Announce FDA Acceptance for Review of New Drug Application for Oral Antibiotic Faropenem Medoxomil
02.15.2006
Forest Laboratories Revises Research and Development Spending Projection to Account for Upfront Payments for Two Recent In-Licensing Transactions
02.13.2006
Replidyne and Forest Laboratories Announce Faropenem Medoxomil Licensing Agreement
01.17.2006
Forest Laboratories, Inc. Reports Q3'06 Diluted Earnings Per Share of $0.57 Including $0.05 Per Share Licensing Payment
01.11.2006
Mylan Laboratories and Forest Laboratories Announce Nebivolol Licensing Agreement
01.05.2006
Forest Laboratories, Inc. and Cypress Bioscience, Inc. to Commence Third Milnacipran Phase III Trial
01.04.2006
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2006 Third Quarter Earnings
11.28.2005
Gedeon Richter and Forest Laboratories Expand Relationship with Two New Collaborations for CNS Compounds
11.06.2005
Forest Laboratories and Lundbeck Enter Into Settlement Agreement With Alphapharm Related to Lexapro Patent Litigation
11.05.2005
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2006 Second Quarter Earnings
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »